Risperidone long-acting injectable (Risperdal Consta®) for maintenance treatment in patients with bipolar disorder.
about
The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmCurrent and emerging therapies for the management of bipolar disordersThe effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.The diagnosis and treatment of bipolar disorder: decision-making in primary care.A Systemic Review and Experts' Consensus for Long-acting Injectable Antipsychotics in Bipolar DisorderRisperidone versus risperidone plus sodium valproate for treatment of bipolar disorders: a randomized, double-blind clinical-trialSix-month open-label follow-up of risperidone long-acting injection use in pediatric bipolar disorder.Biodegradable polymers derived from amino acids.Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder.1,2-Benzisoxazole compounds: a patent review (2009 - 2014).Stigma and higher rates of psychiatric re-hospitalization: São Paulo public mental health system.Depot Subcutaneous Injection with Chalcone CH8-Loaded Poly(Lactic-Co-Glycolic Acid) Microspheres as a Single-Dose Treatment of Cutaneous Leishmaniasis.
P2860
Q28066714-FEDE95BA-2F3C-42BF-9F33-87B3B0076A55Q28686902-B7E9299F-DD80-4AAC-99CC-A895AC905606Q33619940-793AB291-4F8B-4C71-8996-5E6BABD74A86Q33878816-CAF23317-76F6-48AF-9153-9B42BD699FEEQ34331882-CF1B8B97-4333-40FD-B0BA-139C17ECBE3CQ35965634-E757CA1E-73DC-408B-9B6C-3661AF4094D0Q36780394-CD1BF182-D40E-41F4-BE35-C015C90BED7BQ37226984-0C3F5015-B335-4ADA-A72B-4AD056F003BEQ37952641-36895B54-EBEA-4BD8-B911-E5386EAAD360Q38003196-3DC54696-D246-4891-8FFA-6D0CB05549EEQ38387758-04AC07B6-939D-4D10-BCF3-2B166BFD8E87Q40043812-C67261E7-B8A8-4331-8FC2-668D993D43AAQ51771418-FC563A34-49A8-4925-BB97-88A09B85FC07
P2860
Risperidone long-acting injectable (Risperdal Consta®) for maintenance treatment in patients with bipolar disorder.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Risperidone long-acting inject ...... atients with bipolar disorder.
@en
Risperidone long-acting injectable
@nl
type
label
Risperidone long-acting inject ...... atients with bipolar disorder.
@en
Risperidone long-acting injectable
@nl
prefLabel
Risperidone long-acting inject ...... atients with bipolar disorder.
@en
Risperidone long-acting injectable
@nl
P2860
P356
P1476
Risperidone long-acting inject ...... atients with bipolar disorder.
@en
P2093
Richard C Shelton
William V Bobo
P2860
P304
P356
10.1586/ERN.10.143
P577
2010-11-01T00:00:00Z